Article
Estimating cancer survival and clinical outcome based on genetic tumor progression scores.
Bioinformatics (Oxford, England) - 15 May 2005
Rahnenführer Jörg, Beerenwinkel Niko, Schulz Wolfgang A, Hartmann Christian, von Deimling Andreas, Wullich Bernd, Lengauer Thomas
Abstract excerpt
MOTIVATION: In cancer research, prediction of time to death or relapse is important for a meaningful tumor classification and selecting appropriate therapies. Survival prognosis is typically based on clinical and histological parameters. There is increasing interest in identifying genetic markers that better capture the status of a tumor in order to improve on existing predictions. The accumulation of genetic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
